Discovery Projects - Grant ID: DP110103969

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/DP110103969

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Lymphotropic prodrugs: a novel mechanism for targeted drug delivery. This project aims to design chemically modified drugs that target drug delivery specifically to white blood cells. This approach promises to maximise drug action and simultaneously reduce toxicity for diseases where lymphocytes are the major drug target. These include autoimmune disease, leukaemia, lymphoma, HIV, transplant rejection and diabetes.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-07-2015

Funding Scheme: Discovery Projects

Funding Amount: $450,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmaceutical Sciences | Medicinal and Biomolecular Chemistry | Biologically Active Molecules | Medicinal and Biomolecular Chemistry not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

Human Pharmaceutical Treatments (e.g. Antibiotics) | Immune System and Allergy |

Other Keywords

Biologically Active Molecules | Human Pharmaceutical Treatments (e.g. Antibiotics) | Immune System and Allergy | Medicinal and Biomolecular Chemistry | Medicinal and Biomolecular Chemistry not elsewhere classified | Pharmaceutical Sciences

Related Links